If you have been reading about Pentadecapeptide and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-12-26. Where a claim depends on a specific study, the study is described rather than over-claimed.
BPC-157 is a synthetic peptide of fifteen amino acids, written in single-letter code as GEPPPGKPADDAGLV. The sequence corresponds to a partial fragment of a protein isolated from human gastric juice, described in early reports as body protection compound. The number 157 refers to a fragment designation in that work rather than to molecular mass. Initial descriptions appeared in the early 1990s, when the fragment was reported to protect gastrointestinal tissue in animal models. Commercial material is produced by solid-phase peptide synthesis rather than extracted from biological sources.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
BPC 157 is a synthetic peptide built from fifteen amino acids. The letters stand for body protection compound, and the number is a laboratory code rather than a description of any biological feature. Its single-letter sequence is GEPPPGKPADDAGLV, which corresponds to a calculated mass near 1419.5 daltons. The material is produced by solid-phase peptide synthesis and is distributed as a lyophilized powder, not as a purified extract from a natural source.
Early work on this family of molecules examined fractions of human gastric juice, where a larger protein was reported to protect gastrointestinal tissue in animal models. BPC 157 was designed as a shorter, more stable fragment of that protein and then studied on its own. The peptide itself is not a normal dietary component and is not present in the human body in meaningful quantities. Descriptions of its origin therefore refer to the research lineage of a laboratory molecule rather than to an endogenous or nutritional substance.
| Property | Value | Notes |
|---|---|---|
| Class | Synthetic peptide | Linear, fifteen residues |
| Sequence | GEPPPGKPADDAGLV | Single-letter amino acid code |
| Approximate mass | 1419 Da | Value reported for the free peptide |
| Reported origin | Fragment of a gastric juice protein | Used as the design template |
| Common synonyms | Body protection compound 157; PL 14736 | Naming varies across papers and suppliers |
Long-term storage of the dry powder is typically described at minus twenty degrees Celsius or colder, while shorter holding periods may use ordinary refrigeration. Repeated warming and cooling cycles are discouraged because they stress the material and can promote aggregation or loss. Light exposure and residual moisture are both treated as avoidable sources of degradation, and working aliquots are often prepared to limit how many times a container is opened. Sealed vials with a desiccant are the usual container.
Quality assessment rests on two separate questions: whether the chain is the intended one, and how much of the sample is that chain. Reverse-phase high-performance liquid chromatography with ultraviolet detection is the standard purity measurement, while mass spectrometry confirms identity through the observed molecular mass. Amino acid analysis and sequence verification provide further checks. A reported purity percentage describes the proportion of the sample represented by the main peak, not the amount of peptide by mass, since counter-ions and water make up part of any lyophilized lot.
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
BPC-157 is a synthetic peptide composed of fifteen amino acids. Its sequence corresponds to part of a protein found in human gastric juice, which is the origin of the "body protection compound" label. In laboratory work the material is treated as a defined research chemical rather than a finished product. Published research has centered on animal models, and the peptide is not an approved medicine in most countries.
The peptide was first described in the early 1990s by a group studying gastric secretions and tissue repair. Its fifteen-residue chain is usually written as GEPPPGKPADDAGLV in single-letter code. The free peptide has the formula C62H98N16O22 and a theoretical mass near 1419.5 daltons. These identifiers are established chemical facts that can be checked against standard peptide databases. There is no ambiguity about the primary structure.
Most published findings come from rodent experiments using induced injury or surgical models. Human reports remain scarce and are largely observational, which limits how much can be stated with confidence. Questions about absorption, distribution, metabolism, and clearance in people are still open. Dose translation between species is likewise unresolved. Researchers tend to read the animal literature as a starting point rather than a settled account.
The Sanitary Commission for the Eradication of Hookworm Disease was a Rockefeller-funded campaign from 1909 to 1914 to study and treat hookworm disease in 11 Southern states. Hookworm was known as the "germ of laziness". In 1913, the foundation expanded its work with the Sanitary Commission abroad and set up the International Health Division (also known as International Health Board), which began the foundation's first international public health activities. The International Health Division conducted campaigns in public health and sanitation against malaria, yellow fever, and hookworm in areas throughout Europe, Latin America and the Caribbean including Italy, France, Venezuela, Mexico, and Puerto Rico, totaling fifty-two countries on six continents and twenty-nine islands. The first director was Wickliffe Rose, followed by F.F. Russell in 1923, Wilbur Sawyer in 1935, and George Strode in 1944. A number of notable physicians and field scientists worked on the international campaigns, including Lewis Hackett, Hideyo Noguchi, Juan Guiteras, George C. Payne, Livingston Farrand, Cornelius P. Rhoads, and William Bosworth Castle. In 1936, The Rockefeller Foundation received one of the first awarded Walter Reed Medals from The American Society of Tropical Medicine & Hygiene to recognize its study and control of Yellow Fever. The World Health Organization, seen as a successor to the IHD, was formed in 1948, and the IHD was subsumed by the larger Rockefeller Foundation in 1951, discontinuing its overseas work.
==== Human Resource Management ==== A practical application of positive psychology is to assist individuals and organizations in identifying strengths so as to increase and sustain well-being. Therapists, counselors, coaches, various psychological professionals, HR departments, business strategists, and others, are using new methods and techniques to broaden and build upon the strengths of a wide population of individuals. This includes those not suffering from mental illness or disorder.
=== Precursors to chlorinated cyanurates === Cyanuric acid is mainly used as a precursor to N-chlorinated cyanurates, which are used to disinfect water. The dichloro derivative is prepared by direct chlorination:
Sources: en.wikipedia.org
== Natural abundances of micronutrients == The natural abundance of elements is dependent on their atomic number based on the process of nucleosynthesis such that elements with higher atomic numbers are typically less abundant than elements with low atomic numbers. Most micronutrients are trace elements with high atomic numbers, meaning they exist naturally in low concentrations. Notable exceptions to this rule are boron (atomic no. 5), manganese (atomic no. 25), and iron (atomic no. 26). Primary producers are the main contributors to the incorporation of micronutrients into a community's chemical inventory. Consumers within an ecosystem are limited to the micronutrients in the tissue of the primary producers which they eat. Primary producers obtain their micronutrients from their surrounding abiotic environment and the recycling of organic matter in soils. For example, grasses take in iron from soils which animals rely upon for hemoglobin production.
== Deaths == January 6 – Alex Felipe, 32, futsal player (Sporting CP, Norilsk Nickel, national team) January 10 – Isabel Veloso, 19, social media influencer January 24 – Constantino de Oliveira Júnior, 57, founder and CEO (2004–2012) of Gol Linhas Aéreas February 4 – Ricardo Schnetzer, 72, voice actor February 13 – José Álvaro Moisés, 81, political scientist. April 17 – Oscar Schmidt, 68, Hall of Fame basketball player (JuveCaserta, Corinthians, national team). April 18 – Oscar Andrade, 68, deputy (1996–2003). April 19 – Gerardo Renault, 96, Minas Gerais MLA (1968–1978), deputy (1978–1986). April 27 – Luciana Novaes, 42, social worker, politician, and Rio de Janeiro city councilwoman. May 4 – Hermano da Silva Ramos, 100, French-Brazilian racing driver (Formula One). May 2 – Raimundo Rodrigues Pereira, 85, journalist. May 5 – Guto Graça Mello, 78, composer and music producer. May 23 – Gabriel Ganley, 22, bodybuilder and social media influencer. June 9 – Orlando Senna, 86, film director (Iracema: Uma Transa Amazônica). June 11 – Brito, 86, football player. June 14 – Oliver Tree, 32, American singer-songwriter. Lucas Frota, 27, record producer, musician, and DJ. June 19 – Brasão, 44, footballer (Athletico Paranaense, Santa Cruz, Salgaocar). July 3 – Lydia Möcklinghoff, 45, German ecologist and zoologist. July 7 – Benedito Ruy Barbosa, 95, telenovela writer (Pantanal, O Rei do Gado, Terra Nostra). July 16 – Renato Machado, 83, newscaster and journalist (TV Globo). July 26 – Octavio Gallotti, 95, minister (1984–2000) and president (1991, 1993–1995) of the Supreme Federal Court.
== Early life == Carrey was born in Newmarket, Ontario, Canada, to Kathleen (née Oram), a homemaker, and Percy Carrey, a musician and accountant. He was raised Catholic and had three older siblings. His mother was of Irish and Scottish descent, and his father was of French-Canadian ancestry; the family's original surname was Carré. At age eight, he began making faces before a mirror and discovered a talent for doing impressions. At age ten, Carrey wrote a letter to Carol Burnett of the Carol Burnett Show pointing out that he was already a master of impressions and should be considered for a role on the show; he was overjoyed when he received a form letter reply. A fan of Monty Python, whose television show Monty Python's Flying Circus aired in the 1970s, in 2014 Carrey appeared on Monty Python's Best Bits (Mostly) and recalled the effect on him of Ernest Scribbler (played by Michael Palin) laughing himself to death in "The Funniest Joke in the World" sketch. Radio Times states, "You'll see why immediately: Palin's performance is uncannily Carreyesque." Carrey spent his early years in the borough of Scarborough, Ontario, part of Metropolitan Toronto, where he attended Blessed Trinity Catholic Elementary School in North York. His family later moved to Burlington, Ontario, where they would spend eight years; Carrey attended Aldershot High School while there. Some time later, his family became homeless and lived together in a Volkswagen van while teenage Carrey and his brother spent months living in a tent in Charles Daley Park on the Lake Ontario shore in Lincoln, Ontario.
Afamelanotide, sold under the brand name Scenesse, is a medication used to prevent phototoxicity and to reduce pain from light exposure for people with erythropoietic protoporphyria, a rare form of genetic sun sensitivity. Afamelanotide is a melanocortin 1 receptor (MC1 receptor) agonist and a synthetic peptide and analogue of α-melanocyte stimulating hormone. It is administered as subcutaneous implant.
Sources: en.wikipedia.org
It is a synthetic fifteen-amino-acid peptide whose sequence matches part of a protein found in human gastric juice. It is made by chemical synthesis, not purified from tissue. The name derives from an early fragment label, not from a molecular weight.
The sequence corresponds to a segment of a naturally occurring gastric protein, so related sequence material exists in the body. The peptide itself as sold and studied is a laboratory-synthesized product. Whether an identical free peptide circulates naturally is not established.
No major regulatory agency has approved it as a medicine for any indication. It appears in research supply channels and, in some jurisdictions, in compounded preparations. Clinical use therefore sits outside standard approved-product pathways, and regulatory status varies by country.
It is a synthetic peptide. Its design was inspired by a fragment of a protein found in human gastric juice, but the fifteen-amino-acid molecule itself is made in a laboratory and is not a normal component of food or of human tissue in appreciable amounts.